Medlive is honored to have recently shared our research poster at #ACR2025, made possible through collaborations with partners like @ifaiarthritis.bsky.social & @aafanational.bsky.social. 👏

Missed us? Catch up on all the data here: 🔗 bit.ly/3Jqj6it

#ACR2025 is over! Grateful for the chance to dive deep into rheumatology, present Liyoung Kim’s poster, and meet so many inspiring scientists. Thanks to Maria Gutierrez-Arcelus for the support! See you next time! 👋
#Rheumatology #Immunology #ACR

Exclusive: Breaking up immune webs called NETs may offer new way to treat autoimmune disease, early data suggest Neutrolis tests enzyme therapy targeting neutrophil extracellular traps (NETs) in Phase 1 trial, showing promise for autoimmune diseases. Drug cleared symptoms in teen with DNASE1L3 deficiency.

DNA-chopping enzyme that breaks up NETs (neutrophil extracellular traps) may offer new way to fight autoimmune disease, early data from #Neutrolis suggest. The company has raised $50M from Morningside. Read more in my latest exclusive for @endpts.com. #ACR2025 endpoints.news/dna-chopping...

Wonderful session about teaching evidence based medicine at #ACR2025 with Dr. Kiwalkar, Dr. Lin, Dr. Desmarais, and Dr. Donohue! @rheumcorner

It’s been an inspiring few days at #ACR2025! 👏 🌟

Thank you to everyone who stopped by to hear our findings and discuss how #patient-centered digital health education can move the #rheumatology field forward. Catch up: 🔗 bit.ly/47sh4Gx

Congratulations once again to the 2025 Duncan A. Gordon Award winners!

We’re honored to share this special message from the authors reflecting on their research.

🎥 Watch here: youtu.be/D617BX40kpQ

#ACR25 #ACR2025 #Rheumatology

We’re proud to announce the recipients of the 2025 Duncan A. Gordon Award, recognizing excellence in rheumatology research. 🏆

📖 Read the award-winning paper:
www.jrheum.org/cgi/content/...

Congratulations to the authors on this outstanding achievement.

#ACR25 #ACR2025 #Rheumatology

JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis Most patients stayed flare-free, as long as they kept taking the drug

Treatment of giant cell arteritis with the oral drug upadacitinib (Rinvoq) was durably effective when continued for 2 years, results from a phase III trial extension indicated. #ACR2025
www.medpagetoday.com/meetingcover...

#ACR2025

#ACR2025

Moderated an excellent session by these wonderful rheumatologists discussing pearls for medical education. What a group! You can watch the recording via the ACR On Demand Website. @ACRheum #ACR2025

Affibody’s psoriatic arthritis therapy shows long-term promise New 52-week data for izokibep in psoriatic arthritis show sustained efficacy and a favorable safety profile.

Affibody's izokibep shows strong long-term results in psoriatic arthritis. New 52-week data from a Phase IIb/III trial presented at the ACR conference in Chicago

#News #PsoriaticArthritis #Rheumatology #ClinicalTrials #IL17 #Izokibep #ACR2025 #MedicalResearch

Affibody’s psoriatic arthritis therapy shows long-term promise New 52-week data for izokibep in psoriatic arthritis show sustained efficacy and a favorable safety profile.

Affibody's izokibep shows strong long-term results in psoriatic arthritis. New 52-week data from a Phase IIb/III trial presented at the ACR conference in Chicago

#News #PsoriaticArthritis #Rheumatology #ClinicalTrials #IL17 #Izokibep #ACR2025 #MedicalResearch

If your research focuses on remote geographical areas and underrepresented populations, we invite you to submit to our new section, Rheumatology Around the World 🌍.

Visit us at booth #2120. We would be pleased to discuss your work.

🔗 www.jrheum.org/guideforauth...

#ACR25 #ACR2025 #GlobalHealth

Great to see the DoCTIS Atlas on therapeutic drug response across IMIDs presented at #ACR2025! 🧬
Built in the EU project doctis.eu
, this work earned an Excellence in Research Award and now feeds into DarkMatter - Congratulations Toni Julià!

— AI for immune prediction.

#AI4Health #IMIDs

#LADAorg is appreciative of our strong partnerships with our patient advocacy colleagues at the #Lupus Community Booth #2121 at #ACR2025. Kudos for collaborating to improve lives! @lupuschat.bsky.social @michiganlupus.bsky.social @infusionaccessfoundation.org @infusioncenter.bsky.social

#ACR2025

Prof. Michelle Petri

A risk score for proteinuria in the next 10 years that would allow clinicians to identify a high risk subset of SLE pts to target for more frequent measurement of urine protein to Cr AND to consider earlier renal bx at even low levels of proteinuria.

Congrats to Prof. König.

Unlike traditional CAR T (e.g., Anti-CD19) targets CD19 on all B cells, which causing indiscriminate depletion, Anti-9G4 CAR-T and cTCR-T cells offer superior precision.
This significantly reduces the risks of infection and CRS.

Wonderful!
#ACR2025

#ACR2025

PLEASE can we stop saying that mtx is risky in people with ILD, and that we can’t use TNF agents in those with cancer?

They are both persistent worries based on confounded data and have both been show to NOT BE TRUE!

⚡️GCA:

SELECT-GCA III

🥇Sustained remission at W52 UPA15 46.6% UPA7.5 41.2% PBO 29%
No MACE or VTE at W52

🥈 Extension to W104
UPA15 68.6% vs Switch to PBO 28.6%

UPA7.5 70.2% vs Switch to PBO 28.6%

➡️ Switching after year 1 📈 Relapse

#EMEUNET #ACR2025

Year in review Dr Bryant England #ACR2025

⚡️Sjogren’s : Sjogren syndrome❌Sjogren disease✅

⚡️SLE:
1- ACR LN guidelines
➡️CRR is the 🎯
➡️Triple Therapy for the W GC+MPAA+BEL/CNI

2- REGENCY III
CRR at W76: OBI 46% vs PBO 33% 🥇 outcome✅

#EMEUNET #EUMEUNET_Ambassador

🏃Chicago … I wasn’t familiar with your game #ACR2025 #EMEUNET

a poster that says science does n't lie on a blue background ALT: a poster that says science does n't lie on a blue background

Traveling to the annual nerd convention. In Chicago #ACR2025 #Rheum so excited

We’re gearing up for #ACR25! ✨

Visit @jrheumatol.bsky.social at booth #2120 in the nonprofit section, Oct 26–28.

Let’s talk rheumatology and publishing! 📝

#Rheumatology #MedicalPublishing #ACR2025

We're presenting our poster outcomes at #ACR2025 in Chicago on 10/28! Proud to align with the American College of Rheumatology's (ACR) mission to advance #rheumatologic care through education that empowers #patients & #clinicians.

Stay tuned for details & read more here: 🔗 bit.ly/42EibBB

I'll be at #ACR2025 this weekend and afterwards flying to Florida for a couple of days at Universal Studios Orlando with family

I'm sure ACR will be great, but I'm *really* looking forward to Islands of Adventure and Epic

If you'll be at ACR (or Islands of Adventure) feel free to get in touch! 🤠

Image from article in Radiology: Artificial Intelligence

#DeepLearning model accurately detected & classified focal #liver lesions https://doi.org/10.1148/ryai.240531 #ACR2025 #RadQI #RadSafety #HITRad #AI #radiology #informatics

Image from article in Radiology: Artificial Intelligence

Single Inspiratory Chest CT-based Generative Deep Learning Models to Evaluate Functional Small Airway Disease https://doi.org/10.1148/ryai.240680 #ACR2025 #RadQI #RadSafety #HITRad #AI #radiology #informatics

Image from article in Radiology: Artificial Intelligence

#CoRaX demonstrated potential to aid radiologists in detecting abnormalities on CXRs by identifying & correcting perceptual errors https://doi.org/10.1148/ryai.240277 @uh.edu #ACR2025 #RadQI #RadSafety #HITRad #AI #radiology #informatics

Image from article in Radiology: Artificial Intelligence

#LLMs using radiology retrieval-augmented generation (RadioRAG) showed variable performance in answering case-based radiology questions https://doi.org/10.1148/ryai.240476 @tayebiarasteh.bsky.social #ACR2025 #RadQI #RadSafety #HITRad #AI #radiology #informatics